Who
Susan Shiff
Director
Company insider
Files Form 4 as: Director, Tvardi Therapeutics.
In numbers
- Trades disclosed
- 12
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 26 Jun 2020
- Last trade
- 9 Jun 2026
- Last filed
- 11 Jun 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 9 Jun 2026filed 11 Jun 2026 | TVRD Tvardi Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —6,000 at $0.00 | filing |
| 9 Jun 2026filed 11 Jun 2026 | TVRD Tvardi Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —6,000 at $0.00 | filing |
| 17 Apr 2025filed 21 Apr 2025 | TVRD Tvardi Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —12,000 at $0.00 | filing |
| 4 Jun 2024filed 6 Jun 2024 | TVRD Tvardi Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —195,000 at $0.00 | filing |
| 4 Jun 2024filed 6 Jun 2024 | TVRD Tvardi TherapeuticsBiotechnology | SEC FORM 4 Code A | —150,647 at $0.00 | filing |
| 1 Jun 2023filed 5 Jun 2023 | TVRD Tvardi Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —44,961 at $0.00 | filing |
| 1 Jun 2023filed 5 Jun 2023 | TVRD Tvardi TherapeuticsBiotechnology | SEC FORM 4 Code A | —32,362 at $0.00 | filing |
| 2 Jun 2022filed 6 Jun 2022 | TVRD Tvardi Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —16,996 at $0.00 | filing |
| 2 Jun 2022filed 6 Jun 2022 | TVRD Tvardi TherapeuticsBiotechnology | SEC FORM 4 Code A | —11,876 at $0.00 | filing |
| 3 Jun 2021filed 7 Jun 2021 | TVRD Tvardi Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,800 at $0.00 | filing |
| 3 Jun 2021filed 7 Jun 2021 | TVRD Tvardi TherapeuticsBiotechnology | SEC FORM 4 Code A | —7,200 at $0.00 | filing |
| 26 Jun 2020filed 30 Jun 2020 | TVRD Tvardi Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —38,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.